ERS International Congress, Milan 2017

Browse by day:
Saturday, 09.09.2017
Sunday, 10.09.2017
Monday, 11.09.2017
Tuesday, 12.09.2017
Wednesday, 13.09.2017

 

Sponsored symposia:

Industry Evening Symposium at ERS 2017: “Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics”

Citations should be made in the following way: Authors. Title. Eur Respir J 2017; 50: Suppl. 61, abstract number.


Update on TB: latest news

Oral Presentation
Chairs: R. Ferreira Duarte Bessa Melo (Porto, Portugal), K. Dheda (Cape Town, South Africa)
Late Breaking Abstract - The tuberculosis diagnostic evaluation cascade of care at microscopy centers linked to Xpert MTB/RIF hubs in Uganda
K. Farr (San Francisco, United States of America)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB) : global response
D. Falzon (Geneva, Switzerland)
Congress or journal article abstract
Congress or journal article abstract
Pediatric multidrug-resistant tuberculosis in Belgium: a nationwide retrospective cohort study.
K. Salmon (Tielt-Winge, Belgium)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Provision of systematic testing for active TB in refugees at CPSA centers
L. Barcellini (novara, Italy)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Latent tuberculosis infection in young refugees in Germany a multicentre, cross-sectional study
M. Mueller-Hermelink (Hamburg, Germany)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
What is the optimal follow-up period for TB contacts- experience from a a population-based study in a TB-endemic area
J. Feng (Taipei, Taiwan)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Antibody and host inflammatory biomarker combinations as diagnostic tools for TB disease
R. Jacobs (Cape Town, South Africa)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
IP-10 point-of-care tests for monitoring treatment efficacy in tuberculosis in a low-resource setting
I. Hoel (Bergen, Norway)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation